A16AB19 pegvaliase
ATC group of level 5 – chemical substance · in plain English: medicines for rare metabolic diseases
This site has the patient leaflet or the SPC of 1 medicine in this group.
Active substance: Pegvaliase – all medicines with this substance, also in combinations.
Place in the ATC classification
- A Alimentary tract and metabolism drugs 1,624 medicines
- A16 Other alimentary tract and metabolism products 95 medicines
- A16A Other alimentary tract and metabolism products 95 medicines
- A16AB Enzymes for alimentary tract and metabolism 21 medicines
- A16AB19 pegvaliase 1 medicine
- A16AB Enzymes for alimentary tract and metabolism 21 medicines
- A16A Other alimentary tract and metabolism products 95 medicines
- A16 Other alimentary tract and metabolism products 95 medicines
Medicines
| Medicine | Legal category |
|---|---|
| Palynziq SPC | – |
Other groups of the same level
- A16AB02 imiglucerase 1 medicine
- A16AB03 agalsidase alfa 1 medicine
- A16AB04 agalsidase beta 2 medicines
- A16AB05 laronidase 1 medicine
- A16AB07 alglucosidase alfa 2 medicines
- A16AB08 galsulfase 1 medicine
- A16AB09 idursulfase 1 medicine
- A16AB10 velaglucerase alfa 2 medicines
- A16AB12 elosulfase alfa 1 medicine
- A16AB13 asfotase alfa 2 medicines
- A16AB14 sebelipase alfa 1 medicine
- A16AB15 velmanase alfa 1 medicine
- A16AB17 cerliponase alfa 1 medicine
- A16AB18 vestronidase alfa 2 medicines
Other names of the ATC group
- German: A16AB19 Pegvaliase
- German: A16AB19 Pegvaliase
- Italian: A16AB19 PEGVALIASE
- Turkish: A16AB19 pegvaliaz
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group A16AB19
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.